Sheela discusses why we should encourage more people from BAME backgrounds to apply for senior level roles and be involved in NICE committees.
NICE has announced that Meindert Boysen has been appointed as its director of the Centre for Health Technology Evaluation.
Men suffering with symptoms from an enlarged prostate could be offered a new type of nonsurgical treatment thanks to changes in NICE guidance.
Fiona explains how a new questionnaire could be used to increase healthy food and drink options in hospital retail outlets
Professor Stansby, expert advisor on the VTE guideline, highlights a call for research launched by NICE and NIHR, into the risk assessment tools
Sharon discusses NICE’s learning disabilities guideline and how organisations can work to improve local services
Thines tells us why NICE committees benefit from diverse representation.
NICE says people growing older with learning disabilities need to have annual health checks to help them manage conditions that can quickly affect them as they grow older.
NICE has issued new advice to help doctors quickly spot Lyme disease, so they can offer people NHS treatment as soon as possible.
Deborah steps out of the judging booth to tell us who has been listed as a NICE shared learning award finalist.
NICE is urging councils and health bodies to make sure that people with learning disabilities can access well-designed services and staff with the right skills so they do not need to move away for care or treatment.
Chris tells us why being endorsed by NICE will boost trust in Prostate Cancer UK’s new pathway for professionals.
NICE and Public Health England have published updated guidelines for health practitioners and stop smoking services on the best ways to help people quit smoking.
NICE is calling on local councils to encourage people to be more physically active by improving routes for pedestrians, cyclists and other users.
Mark discusses how the police force is changing to better support offenders with mental health issues.
The Medtech Early Technical Assessment (META) tool has been selected , as an option, to form part of the application process for a £1million grant for developers of innovative medicines, diagnostics and regulated digital technology in a real world clinical setting,
Jillian shares her experience of heavy menstrual bleeding (HMB) and how she hopes the new NICE guidelines will improve treatment for women like her.
Hysteroscopy has been recommended as a first line diagnostic test for women with heavy menstrual bleeding (menorrhagia), in updated NICE guidance.
Emma discusses how her team has been using NICE guidance to help people with osteoarthritis.
Professor May-Chahal explains how NICE guidance will help protect children and young people from abuse.
To mark Rare Disease Day (28 February), Sheela Upadhyaya explains how NICE’s Highly Specialised Technologies (HST) programme has helped to ensure that drugs for very rare diseases are evaluated appropriately and, if approved, are offered to patients who can benefit from them as part of NHS England’s arrangements for specialised commissioning.
Rachel talks about her time on the fellowship programme at NICE.
Physical barriers such as nets and fences at bridges and stations could reduce suicides, NICE says.
Victoria discusses improvements in how NICE works with patients and the general public, which means there are now more ways than ever to get involved
A workshop last month with stakeholders marked the formal start of NICE’s collaborative work to update its 2010 guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
The new guidance recommends three drugs, treating two types of thyroid cancer to be made routinely available in the NHS.
NICE has published draft guidance that does not recommend the drug cerliponase alfa (also called Brineura and made by Biomarin) for children with neuronal ceroid lipofuscinosis type 2 (CLN2) – a very rare inherited condition affecting between 1 and 6 babies each year in the UK.
NICE has invited Tesaro to submit a proposal for including niraparib (Zejula) in the Cancer Drugs Fund (CDF), for treating some types of recurrent ovarian cancer.
Richard talks about the NICE endorsement programme and what it means for his organisation
Up to 1,600 patients with multiple myeloma could benefit from a new oral pill after NICE recommends ixazomib, also known as Ninlaro, for use within the Cancer Drugs Fund (CDF).
NICE recommends the use of a more accurate scan to diagnose and determine the stage of pancreatic cancer in patients.
The majority of sore throats do not need antibiotics and medicated lozenges may only help to reduce pain by a small amount, NICE says.
Professor Carole Longson, director of the Health Technology Evaluation Centre, is to leave NICE to move on to new roles in the life sciences sector.
NICE’s updated guideline on early and locally advanced breast cancer calls for extended hormonal therapy for some women after they’ve taken tamoxifen in order to reduce the risk of their breast cancer coming back.
NICE says that online and mobile programme Deprexis could help adults with depression get faster access to care and it should be tested out in NHS services.
People with suspected late AMD (wet active) should be referred to a macula service within one working day, says NICE in guidance published today.
Jane tells us how she has used NICE guidance to prevent cardiac arrests and promote quality in local care homes.
NICE Scientific Advice has announced that Newcastle University is the first winner of the NICE AdviSeME Prize for its novel prognostic skin cancer test.
Strimvelis, a treatment for an ultra-rare inherited immune deficiency condition that has been dubbed ‘bubble baby syndrome’ has been approved by NICE in final draft guidance.
Health and social care professionals should support people to make decisions who find it difficult, NICE says in new draft guidance.
Multiple sclerosis drug, Extavia, has been approved for routine funding on the NHS, in NICE draft guidance.
Rosie explains how new NICE guidance will help us all in the fight against antibiotic resistance
Children born preterm should be offered developmental check-ups to help identify any problems or disorders early on, NICE has said in its latest draft quality standard.
Updated advice says current evidence on the safety of the procedure shows there are serious, but well-recognised safety concerns.
People with advanced kidney cancer are set to benefit from a new treatment, after NICE has said lenvatinib should be available on the NHS.
NICE Scientific Advice offers a new service for healthcare product developers to check the quality of their economic models.
Adults with eating disorders could benefit from specialised cognitive behavioural therapy which aims to help patients better understand their condition, the new NICE draft quality standard says.
New tests to help diagnose asthma and a change in how medicines are offered can help people take control of their asthma, NICE says in new guidance.
GP surgeries or community clinics should offer to remove earwax if a build-up is contributing to someone’s hearing loss.
NICE has asked Merck to submit a Cancer Drugs Fund (CDF) proposal for an immunotherapy called avelumab.